| Uniprot No# | P0DTC2 |
| Специфичность | SARS-CoV-2 |
| Источник | Mammalian cell |
| Информация о тегах | C-terminal 6xHis-mFC-tagged |
| Регион экспрессии | 319-541aa |
| Описание последовательности | Partial (S1-RBD) |
| Последовательность белка-мишени | RVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNF |
| Чистота | Greater than 85% as determined by SDS-PAGE. |
| ELISA-антитело-связывающая активность | Testing in progress. It is expected to be updated on April 22, 2020. |
| Активность взаимодействия лигандов | Testing in progress. It is expected to be updated on April 22, 2020. |
| Форма | Lyophilized powder |
| Буфер | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
| Восстановление | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference. |
| | |
Наименование: Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial.